HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
414.45
-3.37 (-0.81%)
Aug 31, 2026, 4:00 PM EDT - Market closed

HCA Healthcare Stock Forecast

Stock Price Forecast

According to 25 analysts polled by S&P Global, HCA Healthcare stock has a consensus rating of "Buy" and an average price target of $451.48. The average 1-year stock price forecast is 8.93% higher than the current stock price, while the lowest is $380 (-8.31%) and the highest is $579 (+39.70%).

Price Target: $451.48 (+8.93%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$380$451.48$435$579
Change-8.31%+8.93%+4.96%+39.70%

Analyst Ratings

The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy131313131313
Buy222211
Hold99991010
Sell000000
Strong Sell111111
Total252525252525

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bernstein
Bernstein
Hold
Reiterates
$426
HoldReiterates$426+2.79%Aug 28, 2026
J.P. Morgan
J.P. Morgan
Hold
Maintains
$425
HoldMaintains$425+2.55%Aug 25, 2026
Bank of America Securities
Bank of America Securities
Hold
Reiterates
$400$425
HoldReiterates$400$425+2.55%Aug 10, 2026
Argus Research
Argus Research
Buy
Reiterates
$500
BuyReiterates$500+20.64%Aug 7, 2026
Truist Financial
Truist Financial
Buy
Reiterates
$495
BuyReiterates$495+19.44%Aug 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
78.51B
from 75.60B
Increased by 3.85%
Revenue Next Year
81.62B
from 78.51B
Increased by 3.95%
EPS This Year
29.49
from 28.21
Increased by 4.54%
EPS Next Year
32.11
from 29.49
Increased by 8.88%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
58.75B60.23B64.97B70.60B75.60B78.51B
Revenue Growth
14.01%2.52%7.86%8.67%7.08%3.85%
Gross Profit
22.49B23.18B25.58B28.68B31.37B32.50B
Gross Margin
38.28%38.48%39.37%40.62%41.50%41.40%
Operating Income
9.68B9.05B9.63B10.55B11.97B11.95B
Net Income
6.96B5.64B5.24B5.76B6.78B6.52B
EPS
----28.2129.49
EPS Growth
----28.46%4.54%
Forward PE
14.1113.4514.2512.6015.9014.05
Dividend / Share
1.922.242.402.642.883.11
Dividend Growth
346.51%16.67%7.14%10.00%9.09%7.90%
Free Cash Flow
4.08B3.08B2.87B3.92B5.82B7.66B
No. Analysts
-----22
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High79.4B
Avg78.5B
Low77.3B

Revenue Growth

Revenue Growth202620272028
High
5.1%
Avg
3.9%
Low
2.2%

EPS Forecast

EPS202620272028
High30.41
Avg29.49
Low28.62

EPS Growth

EPS Growth202620272028
High
7.8%
Avg
4.5%
Low
1.5%